Table 8. Summary of corneal haze rates across corneal collagen cross-linking protocols in progressive keratoconus.
A-CXL: accelerated corneal cross-linking; CXL: corneal collagen cross-linking; I-CXL: transepithelial corneal collagen crosslinking using iontophoresis (riboflavin delivery via iontophoresis); NR: not reported
| Study | CXL Protocol | Haze Rate | Severity | Resolution |
| Kortuem et al., 2017 [81] | Dresden | 70.5% | Variable | Progressive improvement |
| Kortuem et al., 2017 [81] | A-CXL | 46.9% | Variable | Progressive improvement |
| Bhattacharyya et al., 2019 [15] | Dresden | All patients | Transient | Resolved by 3 months |
| Ferdi et al. (Registry), 2023 [2] | Dresden | 15.1% at 1 year | Variable | NR |
| Ferdi et al. (Registry), 2023 [2] | Dresden | 1.9% at 5 years | Variable | NR |
| Kandel et al. (Registry), 2024 [24] | Dresden | 3% at 5 years | Variable | Resolution in 77% |
| Kandel et al. (Registry), 2024 [24] | A-CXL | 2% at 5 years | Variable | Resolution in 88% |
| Alqudah et al., 2025 [14] | I-CXL | 7% | Mild | NR |
| Alqudah et al., 2025 [14] | Dresden | 54% mild | Mild | NR |